Drug eluting balloons are medical devices coated with an anti-proliferative drug to prevent restenosis (re-narrowing of the artery) after angioplasty. Drug eluting balloons helps to reduce in-stent restenosis while avoiding the long-term limitation of polymer-based drug eluting stents.
The global Drug Eluting Balloon Market is estimated to be valued at Us$ 667.78 Mn in 2023 and is expected to exhibit a CAGR Of 8.6% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increased adoption of drug eluting balloons can be attributed to advantages over drug eluting stents such as lower rates of restenosis and fewer antiplatelet therapy requirements. Drug eluting balloons avoids the permanent implant of a metal stent and associated long-term antiplatelet therapy requirements. Drug eluting balloons delivers drug to the vessel walls temporarily without leaving permanent polymeric components behind. This reduces inflammation and proliferation of cells, thereby lowering rates of restenosis. The technological advancements to improve efficacy and safety of drug eluting balloons along with growing application scopes is expected to drive the market growth over the forecast period.
Segment Analysis
The global Drug Eluting Balloon Market is dominated by coronary artery disease sub segment. Coronary artery disease has been the leading cause of death globally. As per estimates, approximately 23.6 million people died from cardiovascular diseases in 2016, representing 31% of all global deaths. Of these deaths, nearly 85% were due to heart attack and stroke. Hence, the drug eluting balloon for treating coronary artery disease is the major sub segment driving the overall market growth.
Key Takeaways
The Global Drug Eluting Balloon Market Demand is expected to witness high growth over the forecast period of 2023 to 2030.
Regional analysis shows that North America region currently dominates the market due to advance healthcare infrastructure and higher adoption rates of innovative medical technologies. Europe region is expected to be the fastest growing market owing to increasing investments for research and development activities.
Key players operating in the Drug Eluting Balloon Market are Oracle Corporation (NetSuite Inc.), BatchMaster Software, Columbus Manufacturing, Aquilon Software, CompuTec S.A.(ProcessForce), Datacor Chempax, DESKERA, ERPAG, Fishbowl, Intellect, SAGE GROUP plc, and VAI - Vormittag Associates, Inc.
Get more insights on this topic :
Check more trending articles on this topic:
https://shoutingstars.com/the-rising-future-of-hydrogen-an-eco-friendly-fuel-for-a-greener-tomorrow
